Omeprazole/sodium bicarbonate capsule - Salix Pharmaceuticals
Alternative Names: Omeprazole/sodium bicarbonate OTC; SAN 15; Zegerid Capsules; Zegerid Chewable Tablets; Zegerid OTCLatest Information Update: 07 Apr 2015
Price :
$50 *
At a glance
- Originator Santarus
- Developer Norgine; Salix Pharmaceuticals; Santarus
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Alkalinising agents; Antiulcers; Gastric antisecretories; Small molecules; Sodium compounds
- Mechanism of Action Antacids; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Erosive oesophagitis; Gastro-oesophageal reflux; Heartburn; Peptic ulcer
Most Recent Events
- 01 Apr 2015 Salix Pharmaceuticals has been acquired by Valeant Pharmaceuticals International
- 02 Jan 2014 Santarus has been acquired and merged into Salix Pharmaceuticals
- 01 Feb 2011 Norgine completes a Phase-I trial in Erosive oesophagitis, Gastro-oesophageal reflux and Peptic ulcer (in volunteers) in United Kingdom (NCT01710995)